Future of diabetes-technology: certificate of competency for insulin pumps and continuous glucose monitors.

Imagine that you are a health insurance company executive whose task is to decide whether to reimburse the costs for a new diabetes technology. Unlike other chronic diseases, diabetes requires multiple daily decisions by the client to maintain a path between the twin chasms of hypoglycemia and hyperglycemia that can lead to unwanted and costly consequences for your company. The manufacturer of the new product has generated a colorful and convincing PowerPoint presentation that highlights its product’s advantages, summarizes key aspects of the clinical studies performed during the development process, as well as reports from patients stating how much they benefit from the product. The presentation may also contain figures showing savings on certain aspects of patient care when the device is used regularly. So, what will your decision be?